GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stem Holdings Inc (OTCPK:STMH) » Definitions » Intrinsic Value: Projected FCF

Stem Holdings (Stem Holdings) Intrinsic Value: Projected FCF : $-21.19 (As of Jun. 10, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Stem Holdings Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-06-10), Stem Holdings's Intrinsic Value: Projected FCF is $-21.19. The stock price of Stem Holdings is $0.0305. Therefore, Stem Holdings's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Stem Holdings's Intrinsic Value: Projected FCF or its related term are showing as below:

STMH's Price-to-Projected-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.565
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Stem Holdings Intrinsic Value: Projected FCF Historical Data

The historical data trend for Stem Holdings's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stem Holdings Intrinsic Value: Projected FCF Chart

Stem Holdings Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial - - - -21.19 -21.19

Stem Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.19 -22.39 -21.32 -19.76 -21.19

Competitive Comparison of Stem Holdings's Intrinsic Value: Projected FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Stem Holdings's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stem Holdings's Price-to-Projected-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stem Holdings's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Stem Holdings's Price-to-Projected-FCF falls into.



Stem Holdings Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Stem Holdings's Free Cash Flow(6 year avg) = $-6.01.

Stem Holdings's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Sep23)/0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*-6.00656+-1.718/0.8)/2.800
=-21.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stem Holdings  (OTCPK:STMH) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Stem Holdings's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.0305/-21.190022529378
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stem Holdings Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Stem Holdings's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Stem Holdings (Stem Holdings) Business Description

Traded in Other Exchanges
Address
2201 NW Corporate Boulevard, Suite 205, Boca Raton, FL, USA, 33431
Stem Holdings Inc is involved in a cannabis business. The company is engaged in the manufacture, possession, sale, distribution, and branding of cannabis and its related products. Its brand includes TJ's Gardens; Yerba Buena; Cannavore; Dose-ology and Travis X James.
Executives
Matthew Cohen director, officer: CEO & CFO 1702 COSTA DEL SOL, BOCA RATON FL 33432
Brian John Hayek director 7012 GIRARD ST, MCLEAN VA 22101
Diener Robert Louis Benjamin director 41ULUA PLACE, HAIKU HI 96708
Dennis Suskind director ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282
Rajiv Raj director 438B WOBURN AVE, TORONTO A6 M5M1L7
Jessica Michelle Feingold director 3730 W. 24TH AVE, DENVER CO 80211
Lindy L Sinder director 408 BARGARA LANE, BRYN MAWR PA 19010
Garrett Martin Bender director 506 ANDREWS AVENUE, DELRAY BEACH FL 33483
Adam Berk director, officer: President 9370 GRAND ESTATES WAY, BOCA RATON FL 33496
Steven Shelly Hubbard director, officer: CFO 3496 FARIVIEW WAY, WEST LINN OR 97068